AI assistant
Quanterix Corp — Regulatory Filings 2020
Aug 5, 2020
33531_rf_2020-08-05_67eb9fa9-5a1f-4b19-8353-76a4f4aca5ae.zip
Regulatory Filings
Open in viewerOpens in your device viewer
S-8 1 tm2026427-1_s8.htm FORM S-8
As filed with the Securities and Exchange Commission on August 4, 2020
Registration No. 333-_____
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Field: Rule-Page
Field: /Rule-Page
FORM S-8
Field: Rule-Page
Field: /Rule-Page
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
Field: Rule-Page
Field: /Rule-Page
Quanterix Corporation
(Exact name of registrant as specified in its charter)
Field: Rule-Page
Field: /Rule-Page
| Delaware (State or other jurisdiction of incorporation or organization) 900 Middlesex Turnpike Billerica, MA | 20-8957988 (I.R.S. Employer Identification No.) 01821 |
|---|---|
| (Address of Principal Executive Offices) | (Zip Code) |
2017 Employee Stock Purchase Plan
2017 Employee, Director and Consultant Equity Incentive Plan
(Full title of the plans)
E. Kevin Hrusovsky
President and Chief Executive Officer
Quanterix Corporation
900 Middlesex Turnpike
Billerica, MA 01821
(617) 301-9400 (Name, address and telephone number, including area code, of agent for service)
Copies to:
William T. Whelan, Esq. Megan N. Gates, Esq. John P. Condon, Esq. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. One Financial Center Boston, MA 02111 (617) 542-6000 Facsimile: (617) 542-2241 John Fry, Esq. General Counsel Quanterix Corporation 900 Middlesex Turnpike Billerica, MA 01821 (617) 301-9400
Field: Rule-Page
Field: /Rule-Page
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ¨ | Accelerated filer x |
|---|---|
| Non-accelerated filer ¨ | Smaller reporting company x |
| Emerging growth company x |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
CALCULATION OF REGISTRATION FEE
| Title of — Securities to be | Amount to be | Proposed Maximum — Offering Price Per | Proposed Maximum — Aggregate | Amount of |
|---|---|---|---|---|
| Registered | Registered (1) | Share | Offering Price | Registration Fee |
| Common Stock, $0.001 par value per share | 1,407,715 shares (2) | $27.60 to $32.43 (3) | $ 44,101,603.23 (3) | $ 5,724.39 |
(1) The number of shares of common stock, par value $0.001 per share (“Common Stock”) of Quanterix Corporation (the “Registrant”), consists of an increase of 1,126,172 shares of Common Stock reserved for issuance under the Registrant’s 2017 Employee, Director and Consultant Equity Incentive Plan (the “2017 Plan”) and an increase of 281,543 shares of Common Stock reserved for issuance under the 2017 Employee Stock Purchase Plan (the “2017 ESPP,” and together with the 2017 Plan, the “Plans”), in each case by operation of the “evergreen” provision contained in the applicable plan.
(2) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement covers, in addition to the number of shares stated above, an indeterminate number of shares which may be subject to grant or otherwise issuable after the operation of certain antidilution and other provisions of the Plans.
(3) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) promulgated under the Securities Act. The offering price per share and the aggregate offering price (a) for shares issuable upon the exercise of options granted under the 2017 Plan are based upon the weighted average exercise price of such options and (b) for the remaining shares to be issued pursuant to the Plans are based upon the average of the high and the low price of the Registrant’s Common Stock as reported on The Nasdaq Global Market as of a date (August 3, 2020) within five business days prior to filing this Registration Statement. The chart below details the calculation of the registration fee:
| Securities — Shares issuable upon the exercise of options granted under the 2017 Plan | 321,034 | $27.60 (3)(a) | Aggregate Offering Price — $ 8,860,538.40 |
|---|---|---|---|
| Shares reserved for future grant under the 2017 Plan | 805,138 | $32.43 (3)(b) | $ 26,110,625.34 |
| Shares reserved for future issuance under the 2017 ESPP | 281,543 | $32.43 (3)(b) | $ 9,130,439.49 |
| Proposed Maximum Aggregate Offering Price | $ 44,101,603.23 | ||
| Registration Fee | $ 5,724.39 |
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
EXPLANATORY NOTE
This Registration Statement registers 1,126,172 additional shares of common stock, par value $0.001 per share (“Common Stock”), of Quanterix Corporation (the “Registrant”) under the Registrant’s 2017 Employee, Director and Consultant Equity Incentive Plan (the “2017 Plan”) and 281,543 additional shares of Common Stock under the Registrant’s 2017 Employee Stock Purchase Plan (the “2017 ESPP”), representing increases of Common Stock reserved for issuance under each such plan, in each case effective January 1, 2020 by operation of the “evergreen” provision contained in the applicable plan. This Registration Statement registers additional securities of the same class as other securities for which registration statements filed on Form S-8 of the Registrant relating to one or more employee benefit plans is effective (File Nos. 333-223771 and 333-231373). The information contained in the Registrant’s registration statement on Form S-8 (File No. 333-223771), except for “Item 5 Interests of Named Experts and Counsel” and “Item 8 Exhibits,” is hereby incorporated by reference pursuant to General Instruction E of Form S-8.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 5. Interests of Named Experts and Counsel.
The validity of the issuance of the shares of Common Stock registered under this Registration Statement has been passed upon for the Registrant by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Item 8. Exhibits.
| Exhibit Number | Exhibit Description | Incorporated by Reference herein from Form or Schedule | Filing Date | SEC File/ Reg. Number |
|---|---|---|---|---|
| 4.1 | Form of Common Stock Certificate of the Registrant | S-1 (Exhibit 4.1) | 11/9/2017 | 333-221475 |
| 4.2 | Amended and Restated Certificate of Incorporation of the Registrant | 8-K (Exhibit 3.1) | 12/15/2017 | 001-38319 |
| 4.3 | Restated Bylaws of the Registrant | 8-K (Exhibit 3.2) | 12/15/2017 | 001-38319 |
| 4.4 | Description of Securities | 10-K (Exhibit 4.1) | 3/13/2020 | 001-38319 |
| 4.5 | Warrant Agreement, dated as of January 30, 2018, by and between the Registrant and Azul Divinal Consultoria Unipessoal LDA | 10-K (Exhibit 4.9) | 3/19/2018 | 001-38319 |
| 4.6 | Fourth Amended and Restated Stockholders Agreement, dated as of June 2, 2017, by and among the Registrant and the stockholders named therein | S-1 (Exhibit 4.7) | 11/9/2017 | 333-221475 |
| 4.7 | Fourth Amended and Restated Registration Rights Agreement, dated as of June 2, 2017, by and among the Registrant and the investors named therein | S-1 (Exhibit 4.8) | 11/9/2017 | 333-221475 |
Field: Page; Sequence: 2; Options: NewSection; Value: 1
Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence
Field: /Page
| 5.1 — 23.1 | Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as to the legality of the securities being registered — Consent of Ernst & Young LLP | X — X | ||
|---|---|---|---|---|
| 23.2 | Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in Exhibit 5.1) | X | ||
| 24.1 | Powers of Attorney (included on signature page to this Registration Statement) | X | ||
| 99.1 | 2017 Employee Stock Purchase Plan | S-8 (Exhibit 99.5) | 3/19/2018 | 333-223771 |
| 99.2 | 2017 Employee, Director and Consultant Equity Incentive Plan | S-1/A (Exhibit 10.2.1) | 11/27/2017 | 333-221475 |
| 99.3 | Form of Stock Option Agreement under the 2017 Employee, Director and Consultant Equity Incentive Plan | S-1/A (Exhibit 10.2.2) | 11/27/2017 | 333-221475 |
| 99.4 | Form of Restricted Stock Agreement under the 2017 Employee, Director and Consultant Equity Incentive Plan | S-1/A (Exhibit 10.2.3) | 11/27/2017 | 333-221475 |
| 99.5 | Form of Restricted Stock Unit Agreement under the 2017 Employee, Director and Consultant Equity Incentive Plan | S-1/A (Exhibit 10.2.4) | 11/27/2017 | 333-221475 |
Field: Page; Sequence: 3; Value: 1
Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence
Field: /Page
SIGNATURES
The Registrant. Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Billerica, Commonwealth of Massachusetts, on August 4, 2020.
| QUANTERIX CORPORATION | |
|---|---|
| By: | /s/ E. Kevin |
| Hrusovsky | |
| E. Kevin Hrusovsky | |
| Chairman, President and CEO |
SIGNATURES AND POWER OF ATTORNEY
Each of the directors and officers of Quanterix Corporation whose signature appears below hereby severally constitutes and appoints E. Kevin Hrusovsky and Amol Chaubal and each of them singly, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them singly, for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 of Quanterix Corporation, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them or their substitute may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ E. Kevin | ||
| Hrusovsky | Chairman, President, Chief Executive Officer and Director (principal executive officer) | August 4, 2020 |
| E. Kevin Hrusovsky | ||
| /s/ Amol | ||
| Chaubal | Chief Financial Officer (principal financial officer and principal accounting officer) | August 4, 2020 |
| Amol Chaubal | ||
| Director | August 4, 2020 | |
| John M. Connolly | ||
| Director | August 4, 2020 | |
| Keith L. Crandell | ||
| /s/ Marijn Dekkers, Ph.D. | Director | August 4, 2020 |
| Marijn Dekkers, Ph.D. | ||
| /s/ Sarah E. Hlavinka | Director | August 4, 2020 |
| Sarah E. Hlavinka | ||
| /s/ Martin D. Madaus, Ph.D. | Director | August 4, 2020 |
| Martin D. Madaus, Ph.D. | ||
| /s/ Paul M. Meister | Director | August 4, 2020 |
| Paul M. Meister | ||
| /s/ David R. Walt, Ph.D. | Director | August 4, 2020 |
| David R. Walt, Ph.D. |
Field: Page; Sequence: 4; Options: Last
Field: Sequence; Type: Arabic; Name: PageNo 3 Field: /Sequence
Field: /Page